ArticlePharmaceutics2023

BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA

Sarah J Overby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.